TAP Block Timing Study
Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Jul 2, 2025
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the best timing for giving a type of pain relief called a TAP block, which is an injection that numbs the nerves around the belly area. The study wants to find out if giving this pain relief before surgery starts helps patients feel less pain afterward and reduces the need for stronger pain medicines like opioids, compared to giving it after the surgery has begun. This is being studied in adults having planned (elective) weight-loss surgery or other types of planned belly surgeries.
Adults between 18 and 65 years old who are scheduled for these surgeries and can understand and agree to the study are eligible to join. People who are pregnant, under 18, prisoners, have trouble understanding or agreeing to the study, or are allergic to the numbing medicine won’t be able to participate. If you join, you can expect to receive the TAP block either before or after the surgery starts, and the study team will then check how well it controls your pain and if it helps you use fewer opioids and other pain medicines after surgery. This study has not started recruiting participants yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged between 18 and 65 years
- • Scheduled for elective bariatric surgery or other elective general abdominal surgeries
- • Proficient in English sufficient to understand study procedures and communicate effectively
- • Capable of providing informed consent
- Exclusion Criteria:
- • Individuals under 18 years of age (minors)
- • Pregnant individuals
- • Prisoners
- • Individuals with cognitive impairments or otherwise unable to provide informed consent independently
- • Individuals with known allergies or contraindications to local anesthetics used in TAP blocks
About Weill Medical College Of Cornell University
Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Ny, New York, United States
Patients applied
Trial Officials
Cheguevara Afaneh, MD
Principal Investigator
Weill Medical College of Cornell University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported